Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E63.29 EPS (ttm)1.68 Insider Own11.20% Shs Outstand1.07B Perf Week0.53%
Market Cap113.92B Forward P/E18.47 EPS next Y5.76 Insider Trans-2.71% Shs Float1.07B Perf Month1.24%
Income1.77B PEG5.22 EPS next Q1.36 Inst Own79.20% Short Float1.18% Perf Quarter23.75%
Sales23.87B P/S4.77 EPS this Y-37.00% Inst Trans-0.22% Short Ratio3.50 Perf Half Y42.23%
Book/sh11.22 P/B9.48 EPS next Y5.23% ROA-0.30% Target Price98.07 Perf Year27.60%
Cash/sh6.45 P/C16.49 EPS next 5Y12.12% ROE-1.10% 52W Range73.69 - 107.84 Perf YTD25.89%
Dividend2.25 P/FCF54.68 EPS past 5Y-15.00% ROI6.60% 52W High-1.72% Beta0.28
Dividend %2.12% Quick Ratio1.10 Sales past 5Y0.20% Gross Margin72.90% 52W Low43.82% ATR1.49
Employees40655 Current Ratio1.40 Sales Q/Q9.10% Oper. Margin9.10% RSI (14)59.44 Volatility1.67% 1.37%
OptionableYes Debt/Eq1.06 EPS Q/Q-126.50% Profit Margin-0.60% Rel Volume0.58 Prev Close106.33
ShortableYes LT Debt/Eq0.79 EarningsOct 23 BMO Payout- Avg Volume3.61M Price105.98
Recom2.30 SMA200.15% SMA504.55% SMA20021.85% Volume520,493 Change-0.33%
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-27-16Upgrade Goldman Neutral → Buy
Sep-08-16Upgrade JP Morgan Neutral → Overweight
May-02-16Reiterated Leerink Partners Outperform $96 → $101
Apr-06-16Initiated Societe Generale Hold $78
Dec-28-15Reiterated Leerink Partners Outperform $93 → $95
Dec-07-15Upgrade Deutsche Bank Hold → Buy $85 → $99
Dec-01-15Upgrade Barclays Equal Weight → Overweight $75 → $95
Sep-24-18 07:45AM  Elanco Announces Full Exercise of Additional Stock, Sets Date for Q3 Earnings Business Wire
Sep-21-18 12:16PM  [$$] Lilly Approval to Spur Migraine-Prevention Market in Europe The Wall Street Journal
09:17AM  Market Rallies Despite Trade Worries: 5 Blue-Chip Picks Zacks
07:46AM  Lilly Receives Positive CHMP Opinion for Emgality (galcanezumab) for the Prophylaxis of Migraine in Adults PR Newswire
07:24AM  Lilly migraine drug wins European panel thumbs-up Reuters
Sep-20-18 01:35PM  Animal health firm Elanco surges 41 percent on debut Reuters
01:32PM  Animal health firm Elanco surges 41 pct on debut Reuters
11:37AM  Elanco Animal Health stock soars more than 35% in trading debut MarketWatch
11:00AM  Eli Lilly Prices Animal Health Unit IPO at $24 Per Share Zacks
10:44AM  Elanco CEO on IPO, animal health focus CNBC Videos
08:51AM  Elancos $1.7 billion IPO looks too pricey, and heres why MarketWatch
Sep-19-18 05:38PM  Lilly's Elanco animal health unit's IPO priced at $24/share Reuters
05:31PM  Elanco Animal Health prices IPO above expected range MarketWatch
05:12PM  Elanco Announces Pricing of Initial Public Offering Business Wire
12:01PM  Lilly's Elanco Rises After $1.5 Billion Animal-Health IPO Bloomberg
11:05AM  J&J Files NDA for Erdafitinib in Urothelial Cancer Indication Zacks
08:48AM  Novo Nordisk to Restructure R&D Unit & Lay Off 400 Staff Zacks
Sep-18-18 09:17AM  Bayer (BAYRY) Focuses on Acquisitions, Competition a Concern Zacks
Sep-17-18 06:30PM  Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV Zacks
09:30AM  Teva stock surges 7% after FDA approves migraine medication MarketWatch
Sep-14-18 05:09PM  Eli Lilly Is Selling More Shares of This Biopharma Firm Barrons.com
10:02AM  Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus Zacks
09:29AM  Roche's Child Arthritis Drug's New Formulation Gets FDA Nod Zacks
09:27AM  AstraZeneca's Lumoxiti Gets FDA Nod for Hairy Cell Leukemia Zacks
Sep-13-18 05:01PM  New Lilly Diabetes Center of Excellence Established at the Indiana Bioscience Research Institute PR Newswire
09:15AM  Why Eli Lilly (LLY) is a Great Dividend Stock Zacks
Sep-12-18 09:55AM  Merck's Antibacterial Drug Succeeds in Label Expansion Study Zacks
09:50AM  AbbVie Gets FDA Nod for Venclexta Label Expansion in Leukemia Zacks
09:44AM  Bristol-Myers (BMY) Reports Phase II Data on Psoriasis Drug Zacks
09:11AM  Incyte, Foundation Medicine Partner for Companion Diagnostics Zacks
09:05AM  NCCN and Lilly Support Quality Improvements for Gastric Cancer Care PR Newswire
Sep-10-18 11:54AM  Lilly to Showcase New Data at the 27th European Academy of Dermatology and Venereology (EADV) Congress, Furthering Innovation for Patients with Complex Dermatological Conditions PR Newswire
10:19AM  Glaxo's Nucala Suffers Regulatory Setback, Gets CRL for COPD Zacks
09:15AM  Lilly (LLY) Hits 52-Week High, Can the Run Continue? Zacks
09:00AM  Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz® and Tremfya® in Patients with Moderate-to-Severe Plaque Psoriasis PR Newswire
Sep-07-18 10:21AM  AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status Zacks
08:58AM  Lilly, Teva, Pfizer & Others Await FDA Decisions in September Zacks
Sep-06-18 03:58PM  New Class of Migraine Drug Creates Four-Way Pharma Development Race Benzinga
12:56PM  Lilly's Elanco unit expects IPO to raise up to $1.45 bln Reuters
12:40PM  Lilly's Elanco unit expects IPO to raise up to $1.45 bln Reuters
09:57AM  Large Cap Pharma Stocks Staging a Comeback in Second Half Zacks
07:02AM  Lilly's Elanco unit expects IPO to raise up to $1.45 bln Reuters
07:00AM  Lilly Announces Webcast to Discuss EASD Presentations PR Newswire
07:00AM  Eli Lilly's Elanco sets IPO terms to raise up to $1.45 billion before options MarketWatch
06:53AM  Elanco Announces Launch of IPO Roadshow PR Newswire
Sep-05-18 06:07PM  J&J Submits NDA to the FDA for Depression Drug in Adults Zacks
04:51PM  Could 2018's Best-Performing Big Pharma Stock So Far Go Even Higher Soon? Motley Fool
02:00PM  Lilly Announces Positive Phase 3 Results in Study of Flortaucipir PET Imaging Agent PR Newswire
01:49PM  Eli Lilly Has Trimmed Its Stake in Biopharma Firm Zymeworks Barrons.com
08:02AM  3 Big Stock Charts for Wednesday: FMC, Eli Lilly and Hewlett Packard Enterprise InvestorPlace
05:19AM  Boost for "made in China" medicine as Chi-Med wins key approval Reuters
03:27AM  Boost for "made in China" medicine as Chi-Med wins key approval Reuters
Sep-04-18 05:17PM  Insurance tactic drags down U.S. drug prices in 2nd qtr -analyst Reuters
03:01PM  Insurance tactic drags down U.S. drug prices in 2nd quarter -analyst Reuters
10:08AM  AstraZeneca Up This Year So Far on Favorable Pipeline Updates Zacks
09:31AM  Better Buy: Pfizer Inc. vs. Eli Lilly and Company Motley Fool
Sep-03-18 08:38AM  Sanofi's Blood Disorder Drug Cablivi Gets Approval in Europe Zacks
Aug-31-18 11:42AM  Glaxo's Asthma Drug Gets EU Nod for Pediatric Population Zacks
Aug-30-18 05:00PM  Anne White Promoted to President of Lilly Oncology PR Newswire
Aug-28-18 01:29PM  25 Dividend Stocks That Analysts Love the Most Kiplinger
10:36AM  Pfizer's Tafamidis Fails to Impress in Cardiomyopathy Study Zacks
Aug-27-18 06:19PM  All-Time highs: 6 stocks to buy CNBC Videos
04:30PM  Lilly to Participate in Morgan Stanley Global Healthcare Conference PR Newswire
02:21PM  Rimidi Announces Addition of Jim Clifford as Vice President of Strategic Sales PR Newswire
09:15AM  Is Eli Lilly (LLY) a High-Growth Dividend Stock? Zacks
08:46AM  5 Reasons Why You Should Add Lilly Stock to Your Portfolio Zacks
Aug-26-18 05:33PM  Why Large-Cap Pharma Stocks Like Pfizer and Lilly Might Still Have Upside TheStreet.com
Aug-24-18 08:16AM  Better Buy: Eli Lilly and Company vs. GlaxoSmithKline Motley Fool
Aug-23-18 11:00AM  Pfizer Amends Xtandi Study Protocols to Speed Up Completion Zacks
10:04AM  J&J to Appeal as Judge Confirms Jury Order in Talc Case Zacks
07:52AM  Large-Cap Pharma Rebounds: 2 Stocks to Boost Your Portfolio Zacks
Aug-22-18 09:45AM  Allergan Falls on FDA's Rejection of Uterine Fibroids Drug Zacks
Aug-21-18 08:21AM  Merck Gets FDA Nod for Keytruda Lung Cancer Label Expansion Zacks
Aug-20-18 01:05PM  Drugmakers Extend Summer Rally as Markets Regain Footing Bloomberg
Aug-17-18 05:41PM  Should you trade or fade this week's biggest winners? CNBC Videos
10:23AM  Lilly (LLY) Hits 52-Week High, Can the Run Continue? Zacks
08:15AM  The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns Benzinga
Aug-16-18 02:00PM  Eli Lilly's Overbought Stock Poised to Fall 15% Investopedia
Aug-15-18 05:39PM  [$$] Karuna Appoints Steven Paul as CEO The Wall Street Journal
Aug-14-18 09:25PM  Elanco Animal Health Announces Pricing of $2.0 Billion of Senior Notes PR Newswire
Aug-13-18 09:48AM  Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings Zacks
Aug-10-18 08:08AM  Eli Lilly Stock History Motley Fool
Aug-09-18 10:04AM  Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates Zacks
Aug-08-18 09:15AM  Is Eli Lilly (LLY) a Great Dividend Play? Zacks
Aug-07-18 01:00PM  Why Health Care Stocks Are Outshining The Techs Investopedia
09:50AM  Q2 Earnings Drive Pharma ETFs Higher Zacks
Aug-06-18 04:08PM  Does Bausch Face A Reckoning? 5 Key Issues To Look For In Its Earnings Investor's Business Daily
Aug-03-18 12:39PM  Eli Lilly Breaks Out of a Large Consolidation Pattern, Further Gains Ahead TheStreet.com
07:52AM  The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings Benzinga
07:15AM  Jim Cramer: 4 Pet-Related Stocks That Are Top Dog TheStreet.com
Aug-02-18 07:32PM  Drugmaker Lilly's Elanco animal health unit files for IPO Reuters
06:19PM  Drugmaker Lilly's Elanco animal health unit files for IPO Reuters
05:51PM  Eli Lilly's Animal-Health Business Files for Initial Public Offering Bloomberg
05:40PM  Elanco Animal Health Files IPO Registration Statement PR Newswire
05:24PM  Diabetes Superpower Eli Lilly's Results Motley Fool
Aug-01-18 05:24PM  Here's What's Going On at Eli Lilly and GlaxoSmithKline Motley Fool
04:12PM  Why The 'Heat Wave' For U.S. Pharma Could Continue This Month Investor's Business Daily
02:18PM  Healthcare Bulls Are Feeling Great After Earnings TheStreet.com
09:00AM  Lilly Diabetes Solution Center Now Open to Help People with Insulin Affordability PR Newswire
12:00AM  [$$] Trump is losing the war on drug prices Financial Times
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; and Nektar Therapeutics, as well as has strategic collaboration with Sigilon Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
LILLY ENDOWMENT INC10% OwnerApr 25Sale80.85180,00014,553,614122,895,804Apr 26 12:38 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 16Sale80.0817,3791,391,71028,273Apr 17 03:29 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 13Sale80.145,165413,92345,652Apr 17 03:29 PM
Smiley Joshua LSVP and CFOMar 16Sale79.203,000237,60020,029Mar 20 12:06 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale76.5086065,7901,637Mar 05 03:30 PM
Zakrowski Donald AChief Accounting OfficerFeb 21Sale77.5587667,9342,472Feb 23 05:42 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048048Feb 21 10:28 AM
Zakrowski Donald AChief Accounting OfficerFeb 05Sale81.0990072,9814,130Feb 05 06:39 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 05Sale81.129,625780,780133,201Feb 05 06:37 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 01Option Exercise0.0021,3260152,120Feb 05 06:37 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0015,993065,357Feb 05 06:33 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0021,3260140,809Feb 05 06:31 PM
Mahony SusanSVP & Pres., Lilly OncologyFeb 01Option Exercise0.0021,326060,350Feb 05 06:24 PM
Lundberg Jan MEVP,Science&Tech and Pres. LRLFeb 01Option Exercise0.0036,2520214,295Feb 05 06:21 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0024,5240102,738Feb 05 06:19 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0017,0600107,820Feb 05 06:15 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0021,3260147,980Feb 05 06:12 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.006,398022,107Feb 05 06:09 PM
LILLY ENDOWMENT INC10% OwnerDec 13Sale88.20200,00017,639,176123,075,804Dec 14 11:26 AM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthDec 11Sale86.4612,5001,080,750124,522Dec 13 03:01 PM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 04Sale86.003,532303,75240,048Dec 05 05:35 PM
Mahony SusanSVP & Pres., Lilly OncologyDec 04Sale86.1836,5853,152,89554,885Dec 05 05:32 PM
Zakrowski Donald AChief Accounting OfficerDec 03Option Exercise0.003,28104,167Dec 05 05:48 PM
Fry Stephen FSVP, HR & DiversityDec 03Option Exercise0.007,557086,501Dec 05 05:46 PM
Ricks David APresident & CEODec 03Option Exercise0.005,4960110,059Dec 05 05:43 PM
Zulueta Alfonso GSVP & President, Lilly Int'lNov 10Sale83.672,003167,59143,580Nov 13 12:55 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale86.81205,00017,795,025123,275,804Oct 05 02:56 PM
LILLY ENDOWMENT INC10% OwnerSep 29Sale85.14195,00016,602,601123,480,804Oct 02 03:39 PM